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Abstract—Molecular docking and virtual screening 
experiments require large computational and data resources and 
high-level user interfaces in the form of science gateways. While 
science gateways supporting such experiments are relatively 
common, there is a clearly identified need to design and 
implement more complex environments for further analysis of 
docking results. This paper describes a generic framework and a 
related methodology that supports the efficient development of 
such environments. The framework is modular enabling the 
reuse of already existing components. The methodology is agile 
and encourages the input and participation of end-users. A 
prototype implementation, based on the framework and 
methodology, of a science-gateway-based molecular docking 
environment for recommending a ligand-protein pair for next 
docking experiment is also presented and evaluated. 
Keywords—bioinformatics; modelling; molecular docking; 
science gateway; virtual screening. 
I.  INTRODUCTION 
Molecular docking is a computational simulation that models 
biochemical interactions to predict where and how two 
molecules would bind. Large-scale molecular docking 
simulations are used in areas such as drug discovery where 
they can decrease the amount of wet-lab experiments required. 
Since molecular docking uses the structure of the receptor, 
large-scale molecular docking of hundreds of thousands of 
ligands and one receptor is called structure-based virtual 
screening (virtual as opposed to the robotics-based high 
throughput screening). Although a single docking simulation 
is relatively short, a typical virtual screening experiment, that 
may combine thousands of simulations, is computationally 
demanding, requiring the use of Distributed Computing 
Infrastructures (DCIs). Utilising and accessing such 
computational resources adds an extra level of complexity to 
the task making it increasingly difficult for biomedical 
scientists. Science gateways are widely utilised in this area to 
help bridging this gap.  
Although this field has seen great advancements recently, 
feedback from biomedical scientists shows that there is still a 
significant gap to bridge. Examples for science gateways 
supporting molecular docking and virtual screening 
experiments include several WS-PGRADE/gUSE [1] based 
gateways, such as the MosGrid Portal [2], the AutoDock 
Gateway [3], and the AMC Docking Gateway [4]; as well as 
non-workflow-based pipelines such as the virtual screening 
environment for Windows Azure [5], the supercomputer-based 
[6] or the Linux cluster-based [7] virtual screening pipelines. 
However, there is still a need for more complex environments 
that enable scientists to access a wide range of computing, 
data and network resources for the further analysis of docking 
results. Such environments should support complex scenarios 
where intelligent support can be provided for the more 
efficient execution of large-scale molecular docking 
experiments.   
This paper investigates such scenarios and proposes a generic 
conceptual framework to support the analysis of molecular 
docking results, and a related methodology that uses regular 
input from scientists when developing complex science-
gateway-based environments for the storage, analysis and 
reuse of molecular docking results. It has been developed 
considering biomedical scientists’ requirements collected from 
semi-structured interviews and a literature review of 14 related 
projects including those mentioned in the paragraph above. 
From this generic framework, specific architectures can be 
derived supporting various molecular-docking-related 
analytical scenarios as shown in Section II. Additionally, a 
software development methodology that supports creating 
docking experiments based on this framework is explained in 
Section III. Finally, a prototype implementation of such 
system is presented in Section IV. 
II. GENERIC FRAMEWORK FOR THE ANALYSIS OF MOLECULAR 
DOCKING RESULTS 
The aim of our research was to identify potential similarities in 
the work of biomedical scientists working with molecular 
docking experiments, and to investigate whether a generic 
framework for such application scenarios can be defined. The 
assumption was that based on this generic framework more 
specific science gateway based environments can be 
implemented supporting different application scenarios. As 
these scenarios have large similarity, deriving and 
implementing such specific environments can be speeded up 
significantly. In other words, the aim was to formalise and 
This work was partially supported by the COLA Cloud Orchestration at the 
level of Applications project, Project No. 731574. 
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speed up the development of specific science gateway 
environments supporting various molecular docking scenarios. 
In order to identify typical user requirements, several 
interviews with five scientists from different backgrounds and 
with various degrees of experience with molecular docking 
simulations were conducted. Since the number of the 
interviewees was small and the population localised in London, 
this is a not a representative sample of the world-wide 
population of scientists that use molecular docking simulations. 
However, considering its diversity, the sample was useful in 
producing several conclusions. The interviews aimed at 
identifying requirements of the scientists when performing 
molecular docking experiments and specifying scenarios that 
are not supported by currently available science gateways for 
molecular docking. These scenarios typically represent 
software systems that make a decision based on the molecular 
docking results, mimicking the steps that a scientist needs to 
take after obtaining the results. Some representative and 
identified scenarios are listed below: 
1. Suggest a ligand-protein pair that should be used in the 
next molecular docking, based on protein similarity and 
previous results 
2. Filter docking results which are suitable for wet 
laboratory experiments, based on ligand properties  
3. Find off-target drugs, based on deducing if the estimated 
binding is at an active site 
4. Enable verification of the docking methodology and 
learning from previous docking for novice users 
5. Compare results from different molecular docking tools 
Based on the conceptual similarities of these scenarios and an 
extended review of literature, a generic framework has been 
designed. The design focuses on the similar elements in the 
scenarios and includes the following components (see Figure 
1): 
Molecular Docking Environment (MDE): All scenarios 
include an environment where the molecular docking 
simulation is executed. It could be as simple as running a 
single simulation from the command line on a local computer, 
to more complex such as executing a virtual screening 
experiment on a DCI. This environment includes the software 
tool used for the docking itself, and may also include 
additional elements to connect to a DCI or to provide a high 
level user interface. 
Molecular Docking Results Repository (MDRR): After the 
execution of the molecular docking, the results need to be 
stored as previous molecular docking results are needed by 
various scenarios. The repository should also store 
information about the final decision made by the whole 
simulation environment. 
Additional Tool (AT): The results which have been stored in 
the MDRR are then processed by an AT. This is a generic 
element that describes a tool which takes one or more 
molecular docking results as input and conducts a calculation. 
ATs can refer back to other molecular docking results stored 
in the MDRR, communicate with other ATs, or refer to data 
stored in an Additional Data Source. 
Additional Data Source (ADS): It contains data that is 
relevant for the final decision and usually is an external 
database. 
Decision Maker (DM): All the information processed from 
the various ATs is passed to a DM. This element groups and 
analyses the calculations performed by the ATs in order to 
make a decision. 
The numbers in Figure 1 present the order or flow of events 
through the different elements: 
1. A scientist uses an MDE to conduct the molecular 
docking and the result is uploaded to the MDRR. 
2. The MDRR sends the results to one or more ATs. 
3. An AT may communicate with one or more other ATs.  
4. An AT may look up data stored in the ADS.  
5. An AT may require additional previous molecular 
docking results as input for its calculation.  
6. An AT would provide its calculation results to the DM. 
7. The MDRR may use data from the ADS directly. 
8. Previous results from the MDRR may be used by the DM 
9. The DM may use data from the ADS directly. 
10. Once the analysis is complete and the decision is made, it 
can be passed back to the MDRR. 
11. Finally, the decision is passed to the MDE to visualise it. 
 
Figure 1 – Basic diagram of the Generic Framework 
From this generic framework each specific scenario 
introduced earlier, and also the ones covered in the literature 
review can be derived. For illustration, a basic architecture 
diagram for the first scenario is shown in Figure 2. Similar 
figures for each scenario have been designed and analysed 
demonstrating that the framework is generic enough to support 
at least the five identified scenarios and the 14 related 
solutions covered in the literature. However, these figures are 
not presented here due to limitations in length of the paper.  
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In Scenario 1 (Figure 2) the framework would analyse 
previous molecular docking results and look for good docking 
results that have used a receptor similar to the currently used 
receptor. Based on this, the system suggests a new protein-
ligand pair that would be an interesting candidate for docking. 
Two key issues here are the definitions of good docking result 
or similar receptor.  
In Figure 2 the building blocks of the Generic Framework 
have been replaced with concrete elements supporting this 
particular scenario. One of the advantages of this modular 
design is that these building blocks can be easily replaced with 
other elements if necessary. This way multiple existing tools 
can be integrated into the scenario design and evaluated, 
requiring only the implementation of components that are not 
currently available.  Mapping of the generic framework for 
this particular scenario in the presented example is as follows: 
The MDE is an extended version of the popular Racoon2 [8] 
desktop application, a virtual screening environment. The WS-
PGRADE/gUSE science gateway framework was integrated 
with Raccoon2 to support large-scale experiments on 
heterogeneous cloud computing resources, as it was presented 
in [9]. The MDRR is a custom-made repository based on a 
MongoDB database. Three ATs are utilised in this scenario. 
The structural alignment tool DeepAlign [10] is used to 
calculate similarities between receptors. A custom-made AT is 
used to assess whether the structural alignment result means 
that the two receptors are similar, while another custom-made 
AT is required to assess a docking result and categorise it as 
good. Finally, a custom-made DM is needed to suggest which 
protein-ligand pair to dock next. 
 
Figure 2 – Basic diagram of scenario to suggest a ligand-
protein pair for next docking (Scenario 1) 
The flow of events is shown in Figure 2. Raccoon2 executes 
the molecular docking and the results are uploaded to the 
MDRR (1). The MDRR sends the receptor pairs to DeepAlign 
(2). The results of DeepAlign are assessed by the custom-
made AT (3) that sends the results to the MDRR (4) and the 
DM (5). All past docking results of similar receptors are sent 
to be assessed (6) and the good results are sent to the DM. The 
DM combines the results from the ATs, and suggests which 
protein-ligand pair to dock as a next step. This suggestion is 
returned to the MDRR and stored as meta-data (8). Finally, it 
is presented to the user (9). 
Based on the basic generic architecture of Figure 1, a more 
detailed framework has been developed that consist of a 
diagram, a textual description of elements and interfaces, and 
a formal description using Z-notation [11]. The aim of this 
framework is to describe the generic architecture and the way 
how the specific scenarios are derived from this in a 
formalised way. Based on this formalism we aim to support 
application developers to make specific decisions when 
evaluating and implementing these scenarios. The designed 
framework is independent from the actual implementation, or 
indeed, the programming language of choice. 
The diagram representing the framework in Figure 3 is a 
generic model, showing all generic elements and all possible 
interfaces between them. It is based on the UML Component 
Diagram in the sense that the elements are drawn as 
components and the interfaces between them are the typical 
provided and required interface connections. Additionally, it 
features arrows pointing towards the direction of the flow of 
data in a particular interface. 
 
Figure 3 – Generic Framework diagram 
The framework features 13 interface types between its 
elements. As next step, each of these interfaces have been 
identified and described. For example: 
1. User → MDE, provided by the MDE: allows the user to 
upload the correct input for the molecular docking or 
additional user input values needed by another element. 
2. MDE → user, provided by the MDE: displays the result 
of the molecular docking to the user, along with other 
results from the MDRR.  
Following this, each element and each interface have been 
described formally using Z-notation. As the set of descriptions 
is too extensive for this paper, only a representative example is 
10
th
 International Workshop on Science Gateways (IWSG 2018), 13-15 June 2018 
 
 
presented here, describing the MDE and its interfaces (see 
Figures 4 and 5).  
The docking process expressed by the MDE needs a ligand, 
receptor, and optionally configuration (config) files as input, 
and provides a docking result file as output. When there is no 
config file then the dockingWithoutConfig() function will 
generate the docking result, while when there is a config file 
then the dockingWithConfig() function will do it. Furthermore, 
the Z-notation for dockingWithoutConfig() describes that for 
every ligand × receptor pair, as long as the ligand and receptor 
are not empty files, there exists a docking result. Similarly, 
dockingWithConfig() defines that for each ligand and for each 
receptor there exists a configuration file that can be used to 
produce a docking result. The corresponding Z-notation 
descriptions can be seen in Figure 4.  
 
Figure 4 – MDE Described in Z-notation  
Figure 5 models the MDE and its interfaces for the three types 
of input files. This schema explains that the ligand, receptor, 
and config files are input, while the docking results as well as 
data about the date are produced as output. The lower part of 
Figure 5 describes the interface that enables users to view 
results, as long as they are not non-existent.  
 
Figure 5 – Interfaces of the MDE described with Z-notation 
Based on the above detailed description of the generic 
framework, a detailed architecture diagram of each scenario 
can now be derived followed by the textual and formal 
descriptions of these scenarios. Figure 6 shows part of the 
detailed architecture diagram of Scenario 1, representing the 
extended Raccoon2 as an MDE, and corresponding to that part 
of the basic diagram of Figure 2. In Figure 7 the formal 
description of this module is shown. (Please note that full 
diagram and description are not provided due to limitation of 
length, but has been produced.) 
 
Figure 6 – Extract of the detailed architecture diagram of 
Scenario 1  
 
Figure 7 – Extract of the formal description of Scenario 1 
III. METHODOLOGY FOR DEVELOPING ENVIRONMENTS FOR THE 
ANALYSIS OF MOLECULAR DOCKING RESULTS  
This section describes the methodology for developing 
complex environments that reuse and analyse molecular 
docking results. This methodology complements the 
framework described in the previous section by explaining 
how this framework can be used during development. It 
clearly states the roles that are required and the specific sub-
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projects for which they need to collaborate. The methodology 
is based on the seven principles identified by Cockburn [12]. 
Based on Cockburn’s general recommendations, a role-
deliverable-milestone diagram has been created to represent 
the methodology (Figure 8). This diagram illustrates that the 
modeller, biomedical scientist and bioinformatician should 
collaborate when creating the diagram and textual description 
of the scenario. Furthermore, the modeller should collaborate 
with the bioinformatician and the software developer when 
creating the formal description. Key components of this 
diagram, extensions to Cockburn's original model, are the 
dotted lines which show that the process is agile. For instance, 
in the top section where the life scientist works on the textual 
description and go from milestone M4 to M5, there is a dotted 
line showing that (s)he could revisit and alter the diagram if 
necessary. The same logic is used for the agile development of 
the final system code. Figure 8 presents a high level role-
deliverable-milestone diagram where the coding section has an 
asterisk (*) indicating that a similar but more detailed 
description of this section (not presented in this paper) has 
also been developed in the form of a lower-level diagram.  
  
Figure 8 – Role-deliverable-milestone diagram of the 
developed methodology 
IV. IMPLEMENTATION OF THE SELECTED SCENARIO 
In order to demonstrate how the developed framework and 
methodology support implementing molecular docking 
science gateways, an implementation of Scenario 1 
(https://github.com/damjanmk/mdrr-scenarios) is presented 
here. All components in the implementation are accessible via 
a basic RESTful API. We used Bottle [13], a minimalist web-
framework which enables easy server setup.  The MDRR and 
the DM have been deployed on Server 1, the DeepAlign AT 
and the AT to assess the DeepAlign results on Server 2, while 
the docking assessment AT on Server 3 (Figure 9). In order to 
insert results from Raccoon2, the MDRR on Server 1 expects 
zip files as POST parameters. It parses them and inserts 
information into MongoDB, which includes the collections 
receptors, ligands, results, and analysis. Another request is 
sent to continue with Scenario 1 where the MDRR selects all 
receptors from the database, parses and compresses them. 
Next, these are sent to Server 2 along with the target receptor 
(the receptor used in the original simulation), and a threshold 
value (input by the user in Raccoon2). The first AT on Server 
2 executes DeepAlign to find similarities between the target 
receptor, and each different receptor it received. It then calls 
the AT: AssessDeepAlign, located on the same server, in order 
to select the similar receptors. In the simplest form of this AT, 
it assesses the DeepAlign results by comparing the value of 
DeepScore to a user input threshold. A list of these similar 
receptors is returned to Server 1 where the analysis collection 
is updated to keep track of the events so far. Then, the MDRR 
selects past docking results which have used one of the similar 
receptors, and compresses them. It sends a request to Server 3, 
including a threshold value of the AutoDock Vina affinity, 
entered by the user within Raccoon2.  
 
Figure 9 – Architecture of implementation of Scenario 1 
The AT on Server 3 searches through the Vina results for a 
result that has at least one model where the Vina affinity is 
less than the threshold, and calls this a good docking result (a 
Vina docking result can contain for example 10 models). It 
returns a list of good docking results to Server 1.  
Upon receiving this, Server 1 inserts a document in the 
analysis collection before initialising the DM and sending it 
the similar receptors and the good results. The DM combines 
these two lists into one and sorts it based firstly on the 
DeepScore value, then on the affinity. This enables users to 
view an ordered list of results that contain ligands which are 
suggested for a subsequent docking. 
A. Designing the MongoDB database 
At the core of this custom-made MDRR is a MongoDB 
database. There were several reasons why we chose this type 
of non-relational database: 
1. MongoDB’s schеma-less design is ideal because a single 
collection can be used for: input files in different formats, 
output files of any of the over 50 docking tools [14], or 
meta-data about different ATs. 
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2. MongoDB scales very well for large amounts of data, 
provided it is well designed and features such as sharding 
and indexing are utilised. 
3. MongoDB is well-suited for prototyping because it is 
easier to change what is stored during development.  
In this prototype implementation we have considered .pdbqt 
molecules and AutoDock Vina results (as used by Raccoon2).  
The ligands collection contains molecular properties 
calculated using the OpenBabel and PyBel [15] Python 
modules such as canonical_SMILES, logP, mol_weight, etc. 
Biomedical scientists at the University of Westminster were 
consulted when deciding which properties to store. Both the 
ligands and receptors collections include the full parsed 3D 
structure from the .pdbqt files. Each line of the .pdbqt file is 
stored as an element of an array. The structure of each 
molecule should be unique. However, the structure itself 
cannot be uniquely indexed due to size limitations, so we have 
introduced structure_id - an MD5 hash of the structure. This 
uniquely describes the structure and allows for a MongoDB 
index to be created.  
The results collection contains references to the ligand and 
receptor used, specific properties extracted from the result 
files (e.g. CPUs, random_seed), a list of the result models, 
each model containing affinity, rmsd_from_best, and the 
parsed model segment of the Vina result. The parsing process 
is simple – it stores all lines between MODEL and ENDMDL 
as elements of an array. 
B. Use of the framework and methodology 
The framework was followed as described in Section II. A list 
of documented meetings and events is not presented with this 
paper, but serves as supporting evidence of following the 
methodology. The required roles were taken up by different 
researchers at the University of Westminster (with some 
doubling as multiple roles). The presented implementation 
proves that following the methodology such molecular 
docking framework can be implemented. Work is currently 
ongoing to quantify advantages when compared to more ad-
hoc implementation. 
C. Limitations of the prototype implementation 
Due to the Global Interpreter Lock (GIL), Python is not the 
optimal language for multi-threading without additional 
optimisations. Furthermore, Bottle uses a non-threading type 
of servers by default, so using a different specialised server 
would improve performance for simultaneous users. The 
number of items in the collections may become too big to be 
included in one zip file which is used to transfer data from 
servers and sending large files through the network could be a 
bottleneck. Finally, the current DM joins and sorts two lists 
without specific performance optimisations. 
V. CONCLUSION AND FUTURE WORK 
This paper presented a generic framework and a corresponding 
methodology to implement complex science-gateway-based 
environments for the execution of molecular docking 
experiments extended with the intelligent analysis and 
utilisation of docking results. The framework incorporates a 
diagram, and textual and formal description enabling a modular 
design and the replacement and reuse of components. The 
methodology involves multiple stakeholders and requires their 
collaboration in an agile manner. In order to demonstrate the 
usability of the above, a scenario for suggesting a ligand-
protein pair for next docking was also presented. 
Future work includes the implementation and detailed 
evaluation of multiple scenarios to identify, and where possible 
quantify, the advantages provided by the framework and 
methodology. In order to achieve this, the implemented 
solutions are compared to state-of-the-art methods and 
environments to demonstrate the added value of our research.   
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